$AXGN stock has now risen 8% today, according to our price data from Polygon. There has been approximately $3,557,406 of trading volume.
It has been the 177th most-searched ticker on Quiver Quantitative over the last day, out of 10,672 total tickers searched.
Here is what we see in our data on $AXGN (you can track the company live on Quiver's $AXGN stock page):
$AXGN Insider Trading Activity
$AXGN insiders have traded $AXGN stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- WILLIAM P. MR. BURKE has made 0 purchases and 14 sales selling 136,536 shares for an estimated $2,864,659.
- JOSEPH A. TYNDALL sold 26,931 shares for an estimated $288,700
- GUIDO J NEELS sold 4,073 shares for an estimated $43,214
- AMY MCBRIDE WENDELL sold 4,073 shares for an estimated $43,214
- JOHN JOHNSON sold 4,073 shares for an estimated $43,214
- ALAN M LEVINE sold 4,073 shares for an estimated $43,214
- KATHY JOHNSON WEILER sold 4,073 shares for an estimated $43,214
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) sold 1,137 shares for an estimated $18,521
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AXGN Hedge Fund Activity
We have seen 86 institutional investors add shares of $AXGN stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,276,487 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $22,772,528
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,172,029 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,716,514
- BESSEMER GROUP INC added 810,951 shares (+inf%) to their portfolio in Q3 2025, for an estimated $14,467,365
- BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
- BALYASNY ASSET MANAGEMENT L.P. removed 551,516 shares (-28.6%) from their portfolio in Q3 2025, for an estimated $9,839,045
- QUBE RESEARCH & TECHNOLOGIES LTD removed 545,153 shares (-74.8%) from their portfolio in Q3 2025, for an estimated $9,725,529
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 459,707 shares (+1578.6%) to their portfolio in Q3 2025, for an estimated $8,201,172
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AXGN Revenue
$AXGN had revenues of $60.1M in Q3 2025. This is an increase of 23.51% from the same period in the prior year.
You can track AXGN financials on Quiver Quantitative's AXGN stock page.
$AXGN Analyst Ratings
Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 12/01/2025
- Canaccord Genuity issued a "Buy" rating on 10/30/2025
- Citizens issued a "Market Outperform" rating on 10/30/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/30/2025
- Raymond James issued a "Outperform" rating on 10/30/2025
To track analyst ratings and price targets for $AXGN, check out Quiver Quantitative's $AXGN forecast page.
$AXGN Price Targets
Multiple analysts have issued price targets for $AXGN recently. We have seen 5 analysts offer price targets for $AXGN in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
- Caitlin Cronin from Canaccord Genuity set a target price of $27.0 on 10/30/2025
- David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
- Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025
- Yi Chen from HC Wainwright & Co. set a target price of $26.0 on 10/30/2025
You can track data on $AXGN on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
